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Abstract
Background:  People age at remarkably different rates, but how to estimate trajectories of
senescence is controversial.
Methods: In a secondary analysis of a representative cohort of Canadians aged 65 and over (n =
2914) we estimated a frailty index based on the proportion of 20 deficits observed in a structured
clinical examination. The construct validity of the index was examined through its relationship to
chronological age (CA). The criterion validity was examined in its ability to predict mortality, and
in relation to other predictions about aging. From the frailty index, relative (to CA) fitness and
frailty were estimated, as was an individual's biological age.
Results: The average value of the frailty index increased with age in a log-linear relationship (r =
0.91; p < 0.001). In a Cox regression analysis, biological age was significantly more highly associated
with death than chronological age. The average increase in the frailty index (i.e. the average
accumulation of deficits) amongst those with no cognitive impairment was 3 per cent per year.
Conclusions: The frailty index is a sensitive predictor of survival. As the index includes items not
traditionally related to adverse health outcomes, the finding is compatible with a view of frailty as
the failure to integrate the complex responses required to maintain function.
Background
Although the prevalence of both illness and functional
impairment rise with age, individuals with same chrono-
logical age vary widely in health and function [1]. How
best to summarize this variability in impairments is not
clear. While functional disabilities tend to follow a hierar-
chical pattern, [2–4] summarizing disabilities without ref-
erence to the associated illnesses omits important
information. Broader concepts, with a more rigorous the-
oretical base, such as frailty [1] and allostatic load [5],
have been proposed as a better means of assessing the het-
erogeneity of health status amongst elderly people, but
none has yet proved entirely satisfactory [6–9].
We recently proposed that the concept of functional age
can be derived from a representative database which in-
cludes information on a range of variables [10]. Earlier,
we identified a constellation of signs and symptoms from
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this database which show synergy (close inter-relatedness
in complex patterns) in health and loss of synergy in neu-
rodegenerative disease [11]. Recalling that both advanced
age and the frail state are associated with loss of complex-
ity and resiliency and, ultimately, with death [7,12–15]
we now extend these observations to propose that, as a
first approximation, an individual's health status can be
quantified as the proportion of ageing associated deficits
which they have incurred. Further, we suggest that both
fitness and frailty can be estimated by comparing the
number of symptoms and signs (jointly referred to herein
as deficits) which are present in an individual with the
mean number of deficits present in others of the same
chronological age.
Materials and methods
Sample
These data come from the inception cohort of the Canadi-
an Study of Health and Aging (CSHA) [16], a representa-
tive survey of people aged 65 and over. The chief goals of
the CSHA were to identify the prevalence, incidence out-
comes of and risks for dementia. In the first phase (CSHA-
1) data collection took place between February 1991 and
May 1992. In Figure 1, the sample population is presented
as a flow chart. Initially, 10,267 people were interviewed
– 9,008 in the community, and the remainder in long-
term care institutions. The response rate in the communi-
ty was 72 % and was 82% for those in long-term care. Par-
ticipants in the clinical component were selected from a
random sample of elderly Canadians, based on their score
on the Modified Mini-Mental Status Examination (3 MS)
[17]. Those who screened positive, and a sample who
screened negative were invited to a clinical examination
designed to detect cognitive impairment and diagnose its
cause (n = 2914). Demographic and diagnostic details
have appeared elsewhere [16,18–20]. Briefly, of the 2914
who came for a clinical examination 64.4% were women.
Their mean age at baseline was 82.0 years; SD 7.43, range
65–106. Dementia, and its subtypes, were diagnosed and
staged by standard protocols, [16,19,20] based on the ex-
amination and an informant interview, in 1132 people.
Of the remainder, 861 were classified as having Cognitive
Impairment No Dementia (CIND) [19] and 921 with no
cognitive impairment. All 1338 surviving clinical partici-
pants received a follow-up examination approximately
five years after the baseline assessment [20]. Date of death
was recorded for 1465 of the 1521 subjects who did not
survive. The median time to death was 33 months.
Selection of deficits
To select the signs and symptoms for analysis, we have
had to compromise between the desire to use as many
items as possible from the database (more than 400 items
were available) and the need to minimize noise due to
measurement error, including missing data. Therefore, at
this early stage of our investigations, we have restricted
ourselves to deficits that represent a variety of functions,
and at the same time, occurred with reasonable frequency
(on average, in 26.7% of subjects) had minimum (on av-
erage 12%) missing data, and maximum variability across
the database. Our earliest studies demonstrated that tak-
ing into account from 19 to 26 signs and symptoms (de-
pending on the specific applications) we were able to
address different aspects of cognitive aging from diagnos-
tics [21,22] to functional decline [23]. The most impor-
tant finding of the initial studies was the demonstration
that the deficits are not independent. In other words, the
variables are closely interrelated and, in a sense, any defi-
cit contains some information about many of the others
[11]. This implies that even a restricted set of deficits,
which show the above properties can represent a wide va-
riety of impairments. In a prior analysis, we identified a
set of 20 symptoms, signs, impairments and disabilities
(referred to collectively as deficits) that represent loss of
functional activities, sensory impairment, and general
medical, health and behavioural problems [10,11]. The
variables represent deficits, which are more common with
age and include informant-based (e.g. data on function
from CAMDEX H) [16] observer-assessed (e.g. clinical re-
ports of hypertension, diabetes) and test (e.g. 3 MS) data.
The list of deficits is presented below. (The numbers in pa-
rentheses refers to their position in Figure 6 and corre-
spond to those used in [27]). Vision loss (22), hearing loss
(23), impaired mobility (3), vascular problem (36), gait
abnormality, impaired vibration sense (56), difficulty toi-
leting (11), difficulty cooking (7), difficulty bathing (10),
difficulty going out (6), difficulty grooming (9), skin
problems (40), resting tremor (47), changes in sleep (2),
difficulty dressing (8), urinary complaints (29), gastro-in-
testinal problem (28), diabetes (31), hypertension (24),
limb tone abnormality (46).
Analysis
We considered binary deficits (represented by either 1 or
0), depending on their presence or absence in a given in-
dividual. For simplicity, we considered the proportion of
the deficits in the i-th individual (0 < qi < 1) as a state var-
iable, measuring an individual degree of impairment and
frailty. We analyzed the proportion q(t) averaged across
all subjects at age t, for those with no cognitive impair-
ment and checked the hypothesis of the linear increase of
ln(q) with age, as a test of the construct validity of our
model. Regression techniques were applied to estimate
the parameters of the linear model. Cox proportional haz-
ards regression with covariates and Gompertz's model
were used in analysis of the survival data to test the crite-
rion validity of the index in relation to death. The signifi-
cance level was set at p < 0.05.BMC Geriatrics 2002, 2 http://www.biomedcentral.com/1471-2318/2/1
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Results
The impairment index, q ranged from 0 to 1. At any given
age, the impairment index is distributed about the mean
value for individuals of that age. Figure 2 illustrates this
for subjects aged 77 years old who did not demonstrate
cognitive impairment. An individual's health status, fi
may be defined as a ratio of that person's impairment in-
dex to the mean index value, averaged across individuals
without cognitive impairment, but of the same chrono-
logical age: fi = qi/m; f > 1 if the individual is frail and f <
1 if the individual is fit. The logarithm of the ratio ln(f)
may also be considered as an appropriate index of relative
frailty/fitness; a positive value of the logarithm indicates
frailty, whereas a negative value indicates fitness. (When
relative fitness/frailty is to be measured as a dichotomous
variable, the mean case is taken as fit; i.e. f < 1.) Figure 3
presents the proportion of fit and frail people who sur-
vive, averaged by 5-years intervals. As expected, this de-
creases with age for both groups, but note that a higher
proportion of fit individuals than frail survive in each age
group.
Figure 4 presents the log of the mean value of the frailty
index. Consistent with our hypothesis, the frailty index
value increases with age. Because age and the frailty index
are well correlated (r = 0.91, p < 0.001) we can use this in-
formation to estimate relative fitness and frailty, with rea-
sonable precision, across the age spectrum. The regression
line corresponds to the equation:
ln(q) = - 4.23 + 0.03 t   (1)
For example, according to equation (1), after elementary
calculations, 67, 77 and 87 year old individuals expect to
have the following proportions of deficits, m = 0.11, 0.15
and 0.2, respectively. Now consider a 67 individual with
3 deficits from the list of 20. The proportion of deficits q
= 0.15, and therefore such individual may be considered
as frail since q > m = 0.11. However, a 87 years old indi-
vidual with the same q would be considered as fit, since q
< m = 0.2. In other words, the frailty index represents rela-
tive fitness and frailty, so that a given degree of fitness at age
87 may represent frailty at age 67.
A separate, but related way of quantifying relative frailty
and fitness is to use equation (1) as a calibration tool,
which again can be done because it holds with a satisfac-
tory degree of certainty (r = 0.91 corresponding to 83 % of
explained variance). By inverting equation (1) and input-
ting the proportion of deficits, q we arrive at a value of age
t as an output. Calculated in this way, the biological age of
an individual can be understood as the age at which the
average individual has q deficits. Similarly to equation (1)
a precise estimate of relative fitness and frailty can be de-
Figure 1
Population sample flow chart.
CSHA-1 CORE SAMPLE (n = 10,267)
Consented, n = 9008 Community
Consented, n = 1259 Institutions
CLINICAL EXAMINATION (n = 2914)
64.4% women
mean age: 82; SD 7.43; range 65-106yrs.
DEMENTIA
and its subtypes
(n = 1132)
CIND
(n = 861)
NCI
(n = 921)BMC Geriatrics 2002, 2 http://www.biomedcentral.com/1471-2318/2/1
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rived: if the calculated age is less than that individual's
chronological age, he/she is considered fit, if it is greater
than the average age at which people have such deficits,
otherwise he/she considered frail. Such a definition of
frailty therefore depends on two inputs: chronological age
and the proportion of deficits seen at any given age. The
difference between the individual's chronological age and
the expected age given the proportion of deficits can be
used to assess a given individual's relative frailty or fitness.
Recalling the log-linear relationship between the impair-
ment index and chronological age (Figure 4), we suggest
that this value can be used as a first approximation in the
calculation of personal biological age (PBA) by applying
an inverse regression, (regression of age on ln(q)), so that:
PBA = 126.65 + 26.09 ln(q)   (2)
Figure 2
The distribution of the frailty index at chronological age 77
suggests varying levels of fitness and frailty, even in those
with no cognitive impairment.
Figure 3
The proportion of survivals for frail (solid rectangles) and fit
individuals (total rectangles) decreases with the chronological
age. However, frail individuals show lower survival at all age
groups than do fit individuals.
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Figure 4
Mean proportion of deficits at any given age for subjects with
no cognitive impairment. Solid circles represent the propor-
tion of the deficits averaged across all subjects at age CA: In
(q) = - 4.23 + 0.03 CA. Correlation coefficient, r = 0.91, p <
0.0001
Figure 5
Time to death by cognitive diagnostic groups as a function of
chronological and biological age. Solid circles correspond to
average values of time to death (across all subjects of the
particular diagnostic group) with respect to averaged BA dis-
tributed along a straight line (r = - 0.98, p < 0.001). Empty cir-
cles, (o) correspond to time to death with respect to CA and
did not show such a pattern. The following abbreviations are
used for the diagnostic groups: NCI (No Cognitive Impair-
ment), CIND (Cognitive Impairment No Dementia), AD
(Alzheimer's disease), VD (vascular dementia).
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An individual's PBA is defined as the value at which those
deficits are present, on average, in the successfully ageing
group. Chronological (CA) and biological age coincide
when an individual's number of deficits corresponds to
the age given by the equation above. Otherwise, an indi-
vidual may be biologically younger (more fit) or older
(more frail) than their chronological age, and the degree
of relative fitness or frailty can be estimated as the differ-
ence between PBA and CA. For example, a person with 4
deficits from 20 (q = 0.20), according to formula (2) has
an estimated PBA of 83 years. Comparing this value with
his/her chronological age one may consider him/her fit or
frail depending on the difference between PBA and chron-
ological age.
Figure 5 presents the mean months to death, plotted
against mean chronological and biological age, for the
main CSHA cognitive diagnostic groups. As hypothesised,
biological age predicts death in a dose-response relation-
ship. While chronological age has only a weak relation-
ship to time to death, given diagnosis, biological age is
strongly inversely correlated with the time to death (r = -
0.98, p < 0.01).
PBA and CA were compared in relation to survival using
Cox regression, with each as covariates (Table 1). Note
that while the regression coefficients of CA and PBA are
the same, the standard errors are quite different, so that
PBA shows a much stronger relationship with mortality.
Figure 6 serves as a further test of the ability of PBA and
CA to predict mortality. A least squares estimates of the
survival functions using a Gompertz model was fitted to
the survival data for two groups (younger than 80 years
and older than 80 years) for each of CA (panel A) and PBA
(panel B). (The same relationships hold when other ages
are used to dichotomize the sample.) The survival func-
tions clearly show greater differences with PBA compared
with CA, indicating a more refined ability to discriminate
adverse outcomes with the former.
Discussion
We have extended an earlier conceptualization of func-
tional age [10] to present a method of estimating personal
biological age, and from that, to estimate relative fitness
and frailty. In particular, we claim that the proportion of
deficits accumulated by an individual at a given chrono-
logical age allows an operational definition of relative fit-
ness and frailty. To validate this definition of relative
fitness and frailty we compared survival both as function
of PBA in the cohort, and by varying levels of fitness and
frailty within cognitive diagnostic groups.
Calibration equations (1) and (2) comprise our knowl-
edge about the accumulation of deficits in older adults,
and thus can be considered as an example of knowledge
discovery in databases (KDD). KDD is a set of techniques
being developed through a number of disciplines to take
advantage of existing databases as means of discovering
new knowledge. [24,25] KDD, defined as the identifica-
tion of meaningful and useful patterns in databases, in-
cludes both the discovery of previously unseen groupings
within existing databases [11,22] and predictive model-
ling, as also developed in this inquiry.
We are aware of important limitations in our study. First,
in order to initially describe a simple model, we have lim-
ited our analysis to a set of 20 deficits. While these proved
sufficient in earlier analyses, [21–23] alternate formula-
tions of the impairment index may be more efficient. The
more essential the deficits that are taken into account, the
more precise the estimation of frailty that is obtained [26].
However, it is not yet clear which are the essential proper-
ties of signs, symptoms and functional deficits that need
to be selected. This is an ongoing area of investigation, but
it appears that the number of deficits, rather than their
precise nature, might be the most important determinant
[26,27]. We interpret this to mean that frailty might be in-
terpreted as a loss of redundancy in a complex system.
Figure 6
Cumulative proportion of surviving as a function of time to
death for two groups with chronological age (A) and biologi-
cal age (B) less and greater than 80 years. Circles correspond
to experimental data for individuals below 80 years old and
triangles for individuals above 80 years. Curves correspond
to the least square Gompertz's functions (solid lines fit data
for the individuals below 80 years and dashed lines for those
who was older than 80 years).
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In addition, we were limited in our databases to individu-
als aged 65 years and older, and drew from the screened
clinical sample, so that we cannot make a claim about the
representativeness of the data. The incorporation of data
on middle-aged and representative samples should allow
more general claims about PBA to be examined. Third, to
simplify the calculations we have suggested, as a first ap-
proximation, that a state variable can be estimated as the
proportion of deficits. This may seem naive, as if has the
effect of equalizing all the deficits. Evidently, at an indi-
vidual level, not all deficits are equally important: heart
problems or diabetes likely may cause death sooner than
for example, difficulties in getting dressed or skin prob-
lems per se. The finding that the proportion of deficits in a
given individual can include seemingly arbitrary or even
trivial ones requires further investigation. For now, we un-
derstand this finding to mean that accumulating several
deficits results overall in impaired adaptive ability. This is
likely to be the case if the signs are redundant, i.e. if a giv-
en deficit represents a set of others, and if the items of the
index are related. The latter appears to be the case, as illus-
trated in Figure 7, which shows that the deficits are not in-
dependent. The nodes of the graph correspond to the
deficits (numbered in the Materials and methods) and the
edges represent statistically significant relationships be-
tween the deficits (defined as the difference between the
unconditional probability of the occurrence of deficit X
and conditional probability of deficit X given deficit Y)
[11]. This is not surprising when we consider that syner-
getic relationships are typical for age-associated deficits. In
other words, roughly speaking, everything is dependent
on everything else in complex organisms so that changes
in one subsystem affects many others. For example, vision
impairment may be caused by the numerous reasons.
Since vision loss, by itself, is not readily regarded as a life-
threatening factor, it may indicate a more serious problem
(e.g. diabetes, stroke). The more deficits that are used in
deriving the frailty index, the greater the chance that such
secondary signs are linked to serious illnesses. As argued
elsewhere [1,26,28] this is a central aspect of many char-
acterizations of frailty. Moreover, whether this holds for
any combination of deficits (and not just age-associated
ones) additionally requires further study, although we rec-
ognize that such summarization does not allow the influ-
ence of individual disease states to be tested. [22,29]
We considered data together for men and women. The dif-
ferences in mortality of men and women are well known
and we recognise that in the next approximation they
have to be treated separately. However, here we were lim-
ited by the power of data representing, in average, 100 in-
dividuals at each age and division the sample by sex
would make statistics worse. We intend to address the is-
sue of gender differences in accumulation of deficits in the
other paper when dealing with the representative large
sample of data.
Have we offered any special insight beyond the common-
sense observation that as people age they are more likely
to become ill, or that ill people are more likely to die? We
believe that we have. In the first instance, we empirically
derived an index to distinguish biological from chrono-
Table 1: Parameters of Cox regression model for time to death as a function of CA and BA tag for table legends and titles
Variable Beta STD t-value Wald statist p-value
CA 0.0081 0.0038 2.15 4.63 0.0313
BA 0.0081 0.0014 5.70 32.49 <0.000001
Figure 7
Inter signs synergy graph. Nodes indicate the deficits (codes
correspond to the deficits from Methods and [29]) and edges
indicate the statistically significant relationships between defi-
cits, i.e. when the conditional probability of one deficit, given
another is statistically different (p < 0.05; t-test) from the
unconditional probability of the first deficit.
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logical ageing with a result that seems to offer reasonable
precision. For example, equation 2 predicts a maximum
life span 126 years, compared with the maximum-record-
ed life span of about 122 years. This is of interest, but we
have to be careful with its interpretation. We are not
claiming that 126 years is the absolute limit of the human
lifespan. Note that this is an average characteristic of the
sample, in which older adults with deficits have been
over-represented. Moreover, as has been well argued,
there is no evidence for such a limit, and considerable ev-
idence against it [30]. The accumulation of deficits in our
equations suggests a process whereby damage is initially
compensated by redundancy of systems, but when the re-
dundancy is exhausted (i.e., too many deficits are accumu-
lated) any new insult leads to death [31]. Similarly,
equation (1) corresponds to the differential equation re-
lating the proportion of the deficits q to the instantaneous
rate of increase in deficits; i.e. dq/dt: dq/dt = kq (k = 0.03).
In other words, the average annual accumulation of defi-
cits in successful ageing (in this case for individuals with
no cognitive impairment) is 3% per year.
Here we used death as the outcome. However, other ad-
verse outcomes, such as institutionalisation can also be
considered and will be the subject of further inquiry. This
approach also incorporates an important feature of frailty,
which has otherwise received little attention in its opera-
tionalization, namely its relationship to age. While ageing
is readily accepted as being associated with frailty, as ar-
gued elsewhere, [1,26] the notion of frailty finds its roots
in the imprecision of chronological age as an explanatory
model in predicting adverse outcomes in individual cases.
As presented here, PBA represents the individual case, but
its relationship to age is inherent in the definition. As not-
ed (Figure 2), individual values of the impairment index
can vary widely at any given CA. As a statistical analogy,
PBA for a subject represents their individual value; CA rep-
resents the mean. In other words, by taking into account
both the proportion of deficits accumulated by an indi-
vidual at a given age, and the average proportion of defi-
cits estimated from the successful ageing group, we are
able to describe respectively, an individual or a character-
istic of a population. While this is of interest, and served
as the basis of further inquiry [27] we are not making a
claim to have definitively calculated the PBA. Rather, we
have presented one method of so doing, and note that this
approach has properties which encourage us to pursue the
analysis further in other databases.
Conclusions
A frailty index can be estimated as the proportion of defi-
cits older adults accumulate over time. By knowing the
proportion of deficits a given individual has accumulated
at a particular age, personal biological age can be estimat-
ed. Personal biological age for a given individual can be
estimated from their frailty index value, as the age at
which the person has accumulated that frailty index value.
Personal biological age is a stronger correlate of mortality
than chronological age. Relative frailty and fitness can
therefore be estimated as the difference between chrono-
logical and biological age. The frailty index is a sensitive
predictor of survival. As the index includes items not tra-
ditionally related to adverse health outcomes, the finding
is compatible with a view of frailty as the failure to inte-
grate the complex responses required to maintain func-
tion.
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